Video: Every Case Tells a Story| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

Revised Retinopathy Screening Guidelines State Risks Linked to Hydroxychloroquine, Chloroquine

  |  Issue: November 2016  |  

In Asian patients using HCQ or CQ, it will be important to examine the extra macular area as well as the parafoveal region, Dr. Fraunfelder said.

Vanessa Caceres is a medical writer in Bradenton, Fla.

ADVERTISEMENT
SCROLL TO CONTINUE

References

  1. Marmor MF, Kellner U, Lai TY, et al. Recommendations on screening for chloroquine and hydroxychloroquine retinopathy (2016 revision). Ophthalmology. 2016 Jun;123(6):1386–1394.
  2. Melles RB, Marmor MF. The risk of toxic retinopathy in patients on long-term hydroxychloroquine therapy. JAMA Ophthalmol. 2014 Dec;132(12):1453–1460.

Related Articles
    Stock Footage Inc / shutterstock.com

    ACR, Ophthalmologists & Dermatologists Issue Joint Hydroxychloroquine Statement

    Since 1991, hydroxychloroquine (HCQ) has been a staple for the treatment of patients with systemic lupus erythematosus; it has been shown to improve survival, reduce cardiovascular risk, thrombosis and renal damage, delay or prevent lupus cerebritis and more. However, HCQ can potentially bind in the retinal pigment epithelium and cause degeneration of photoreceptors, leading to…

    nukeaf / shutterstock.com

    The History of Treating Lupus with Hydroxychloroquine

    Given how unexpectedly front and center hydroxychloroquine has been in discussions about the treatment of COVID-19 this year, it makes sense to look at how it became so central to the treatment of a rheumatologic condition. In 1991, an article appeared in The New England Journal of Medicine that would alter the way rheumatologists approached…